childhood have a genetic condition that predisposes them to multiple primary neoplasms, such as hereditary retinoblastoma ( 14 , 15 ) , Li -Fraumeni syndrome ( 16 ) , or neurofibromatosis ( 17 , 18 ) . Such genetically predisposed individuals who have been treated with radiotherapy or chemotherapy and who smoke are therefore exposing themselves to a third, additional, source of risk.
Adult survivors of childhood cancer have been found to have lower rates of smoking than the general population ( 19 , 20 ) and healthy control subjects ( 21 -25 ) except in two studies ( 26 , 27 ) that found similar levels of smoking among survivors and control subjects. Factors that have been found to be associated with an increased risk of smoking among childhood cancer survivors include older attained age ( 20 , 24 ) , being female ( 20 ) , being male ( 24 ) , having a low income ( 19 ) , being white ( 19 , 24 , 28 ) , being less educated ( 19 , 20 , 24 , 25 ) , and being 10 years or older at diagnosis ( 19 , 25 ) . Having received particular treatments for childhood cancer has also been shown to be associated with smoking prevalence in survivors; those who received potentially pulmonary-toxic cancer treatments, such as bleomycin, carmustine, or chest irradiation ( 19 ) , or brain irradiation ( 19 , 25 ) were less likely to begin smoking than those who did not have such treatments.
Although survivors of childhood cancer generally smoke less than healthy control subjects and the general population data, some studies ( 22 -24 ) suggest that survivors are less likely to quit smoking than siblings or other control subjects who had not been diagnosed with a childhood cancer. It is therefore important to develop strategies to prevent the initiation of smoking by childhood cancer survivors. In this context, we examined factors that may be associated with initiation of smoking in adult survivors of childhood cancer using data from the British Childhood Cancer Survivor Study (BCCSS), a population-based cohort of most of the adult survivors of childhood cancer in Britain. Because two-thirds of the current smokers in the general population of Britain begin smoking before the age of 18 years ( 29 ) , interventions to prevent smoking are unlikely to be appropriate for the majority of adult survivors of childhood cancer. Therefore, we also examined factors that may be associated with being a current regular smoker among adult survivors of childhood cancer with the goal of identifying factors that could be exploited in the development of a smoking cessation intervention tailored to the specialized needs of this group of individuals. Finally, we compared the extent of smoking among adult survivors of childhood cancer with that in the general population of Britain.
Participants and Methods

Participants
The BCCSS was established to investigate the risks of adverse health and social outcomes among survivors of childhood cancer in Britain. The BCCSS objectives, methods, population structure, response rates, and initial descriptive information are described elsewhere ( 30 ) . The BCCSS is based on a cohort of 17 981 individuals who were diagnosed with cancer during childhood (ie, from birth through 14 years of age) between 1940 and 1991 in Britain and survived for at least 5 years after diagnosis. The cohort was identified using the population-based National Registry of Childhood Tumors, which includes all neoplasms diagnosed in British residents younger than 15 years of age. Among these cohort members, 14 836 were alive and at least 16 years old up to September 17, 2006 (when the Study Co-ordinating Centre stopped dispatching questionnaires); these survivors were eligible to receive a postal questionnaire via their general practitioner. When a survivor ' s current general practitioner could be identified, he/she was requested to send the questionnaire to those eligible survivors for whom there were no known reasons to avoid such contact and for whom the current address was available. The questionnaire was designed to examine the risks of particular adverse health and social outcomes occurring among survivors and thus enable investigation of the variation of such risks in relation to type of childhood cancer and the treatment received (available at http://www.pcpoh.bham.ac.uk/publichealth/cccss/ pdfs/completeq_m.pdf [male version of questionnaire] and http:// www.pcpoh.bham.ac.uk/publichealth/cccss/pdfs/completeq_f. pdf [female version of questionnaire]). Survivors who were impaired to such an extent that they could not complete the questionnaire themselves were asked to have a relative, friend, or a BCCSS staff member (ie, a third party) complete the form with as much input from the survivor as was possible. Most
CONTEXT AND CAVEATS
Prior knowledge
Survivors of childhood cancer are at increased risk of second malignant neoplasms due to the cancer and the treatments they received and, for some, because they have a genetic condition that predisposes them to multiple primary neoplasms. For such individuals, cigarette smoking would be an additional source of risk.
Study design
A population-based cohort study of 17 981 survivors of childhood cancer in Britain in which smoking status and age at initiation of regular smoking were ascertained via a questionnaire.
Contribution
The extent of smoking among survivors of childhood cancer diagnosed in Britain between 1940 and 1991 was less than that seen in the comparable general population. Survivors of Hodgkin lymphoma, soft tissue sarcoma, or Wilms tumor were more likely to be current regular smokers, had greater rates of initiating regular smoking, and had some of the highest odds of current smoking prevalence compared with the general population than survivors of other types of childhood cancer.
Implications
Advice on the health risks of smoking should be included in any program of clinical follow-up for survivors of childhood cancer.
Smoking prevention and cessation interventions should be developed and implemented in this vulnerable group.
Limitations
The self-reported smoking data were based on responses to a questionnaire rather than on biochemical data. Some questionnaires were completed by a third party rather than by the childhood cancer survivor. The analysis did not include information relating to the survivors who had died before their smoking status could be ascertained. 
From the Editors
Measures of Smoking Prevalence and Age at Initiation
Cohort members were classified as current regular smokers (yes, no) and as ever regular smokers (yes, no) based on their responses to two questions: "Do you smoke cigarettes at all nowadays?" and "Have you ever smoked cigarettes regularly?" Those who answered "yes" to the first question and provided their age (in whole years) when they started smoking regularly were classified as current regular smokers. In addition to the current regular smokers, those who answered "no" to the first question and "yes" to the second question were classified as ever regular smokers. The survivors were also grouped according to the number of cigarettes they smoked daily (0 -9, 10 -19, 20 -29, or ≥ 30 cigarettes) and their age at initiation of smoking (0 -12, 13 -16, 17 -20, 21 -24, or ≥ 25 years) using groups established in general population smoking statistics ( 29 ) .
Explanatory Factors Investigated in Relation to Smoking Prevalence and Age at Initiation of Smoking
Survivors were categorized by age group at questionnaire completion, region of residence within Great Britain, sex, childhood cancer type, age group at diagnosis, whether they were on long-term regular hospital follow-up, and whether they had received initial treatment with chemotherapy, radiotherapy, or surgery for their childhood neoplasm. The age at questionnaire completion categories we used were the same as those used in compiling data from questionnaires about smoking prevalence in the general population (16 -19, 20 -24, 25 -34, 35 -49 years) , with the following exception: we combined the two oldest age groups used for the general population data (50 -59 and ≥ 60 years) into one group (ie, ≥ 50 years) because of the small number of BCCSS members who were 50 years or older ( 29 ) . We used the same age-at-diagnosis categories (ie, 0 -4, 5 -9, and 10 -14 years) that were used previously ( 30 ); these groups were chosen because outcomes such as a second malignant neoplasm have been shown to vary among these age-at-diagnosis groups ( 7 ) . Region was based on government office regions in Great Britain ( 29 ) and was established using the survivor's address at questionnaire completion or, if not available, the location of their registered general practitioner. The childhood cancer types were classified as follows: central nervous system (CNS) neoplasm, leukemia (including acute lymphoblastic leukemia, acute nonlymphocytic leukemia, and chronic myeloid leukemia), Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, heritable retinoblastoma (ie, those with a family history of retinoblastoma and/or a diagnosis of bilateral retinoblastoma), nonheritable retinoblastoma, Wilms tumor, bone sarcoma, soft tissue sarcoma, and other neoplasms (which included Burkitt lymphoma, intracranial and intraspinal germ cell tumors, gonadal germ cell tumors, other and unspecified nongonadal germ cell tumors, thyroid carcinomas, malignant melanoma, skin carcinoma, and other less frequent carcinomas). Information on whether the survivor was on long-term regular hospital follow-up (yes, no) came from the survivor's general practitioner. Each questionnaire was initially sent to the survivor's general practitioner, who acted as the "gatekeeper" to the survivor, and the general practitioner was requested to forward the questionnaire to the survivor. The general practitioner was also asked to complete a consent form to enable the BCCSS to contact the survivor directly; this form also asked the general practitioner to indicate whether the survivor was on long-term regular hospital follow-up in relation to his or her childhood neoplastic disease. Initial treatment information was available from the National Registry of Childhood Tumors; however, for some survivors there was no record of whether they were initially treated with chemotherapy, radiotherapy, or surgery and those survivors were excluded from analyses involving these factors (no record: of chemotherapy [n = 3173], of radiotherapy [n = 2930], of surgery [n = 2729]).
We also examined the following social and economic factors: legal marital status, highest level of educational attainment, socioeconomic classifi cation, and whether the questionnaire was completed by a third party. The levels for educational attainment relate to formal educational qualifi cations in Great Britain, which include failure to pass or take any standard public educational examination; level 1 educational attainment, which corresponds to a low level of qualifi cation obtained in Great Britain (eg, General Certifi cate of Secondary Education); level 2 educational attainment, which corresponds to an intermediate level of educational attainment (eg, Advanced Level qualifi cation); and level 3 educational attainment, which corresponds to the highest level of qualifi cation (ie, a fi rst degree or higher). For socioeconomic classifi cation, the survivor's present or most recent occupation was used to classify survivors into "managerial and professional occupations" (highest socioeconomic classifi cation group), "intermediate occupations," or "routine and manual occupations" (lowest socioeconomic classifi cation group) as categorized by national statistics ( 29 ) . Two further classifi cations, "student" and "never worked or unemployed," were added because the BCCSS population had a high proportion in each of these latter classifi cations.
Statistical Methods
We conducted two types of analyses: an internal analysis and an external analysis. All analyses were carried out using Stata statistical software (version 9.0; Stata Corp., College Station, TX).
Internal Analysis. The internal analysis examined factors that were associated with being a current regular smoker and age at initiation of regular smoking within the survivor population. We decided a priori that the following factors should be investigated in logistic regression as possible explanatory factors for being a current regular smoker because of their established association with smoking in general population studies ( 29 ) or their relevance to this cohort of childhood cancer survivors: sex; age at questionnaire completion; type of childhood cancer; age at diagnosis; whether the survivor had received chemotherapy, radiotherapy, or surgery; marital status; socioeconomic classification; level of educational attainment; third-party completion of the questionnaire; and whether the survivor was known to be on long-term regular hospital follow-up. Treatment decade and the interval from 5 years after diagnosis to questionnaire completion were not included in the logistic regression because there was sufficient evidence of colinearity of age at questionnaire completion, treatment decade, and interval from 5 years after diagnosis to questionnaire completion, which made it impossible to assess the separate effects of any one factor adjusted for the others. We decided before the analysis was completed to use the CNS neoplasm survivors as the referent group due to the wide ranges in current age and age at diagnosis and the large sample size of this particular group of survivors.
Tests for heterogeneity (based on the likelihood ratio statistic) were used to investigate the association between each factor and the prevalence of being a current regular smoker, fi rst in univariate logistic regression model and then in multivariable logistic regression models that controlled for all factors identifi ed a priori. Tests for linear trend were undertaken for factors with better than categorical measurement properties by assigning increasing consecutive integer values to levels of the factor and a value of zero to the baseline level (ie, score); tests for evidence of departure from a linear trend were also undertaken using likelihood ratio tests comparing the model with the factor as the categorical variable to the model with the factor as scores. Statistical signifi cance was defi ned as P less than .01, with a two-sided test, because of the large sample size; consequently, 99% confi dence intervals (CIs) are reported.
We used survival analysis to investigate the age at initiation of regular smoking. The age at initiation of smoking was analyzed with entry to risk for initiating smoking from the age at which the subject fi rst came under observation for initiation of smoking, which was the survivor's age at 5 years after his or her diagnosis. Survivors who started smoking before this age but subsequent to diagnosis were excluded from the initial survival analysis, although they were included in the further survival analysis (see below). Exit from risk of initiating smoking (ie, the age at which the subject was last under observation for initiating smoking) was age at smoking initiation for the regular smokers and was defi ned as the age at the midpoint of the year provided on the questionnaire by the survivor; for nonsmokers and never regular smokers, exit from risk (censorship) was the date of questionnaire completion, if available, and otherwise it was the date that we received the returned completed questionnaire. Tests for heterogeneity (from the likelihood ratio statistic) were used to investigate the association between each potential explanatory factor and age at initiation of regular smoking, fi rst in univariate Cox regression models and then in multivariable Cox regression models that controlled for all factors identifi ed a priori, with the exception of socioeconomic classifi cation, marital status, educational attainment, region, and whether on long-term regular hospital follow-up. These latter factors were excluded from the Cox regression because they are timedependent variables that could have changed over the period at risk; however, we did incorporate these factors (as measured at the time of questionnaire completion) into the Cox multivariable regression model to check the sensitivity of the results for the core demographic, cancer, and treatment factors. Tests for trend and for a departure from a linear trend were undertaken for factors with better than categorical measurement properties as described above. Statistical signifi cance was defi ned at the 1% level because of the large sample size. The proportional hazards assumption of the Cox regression was investigated both graphically and by formally testing the Schoenfeld residuals, and no violations were identifi ed. The survival analysis, including the Cox regression, was repeated by including the survivors who started smoking after their diagnosis but before they had reached their 5-year survival date. This further analysis also began at the survivor's age at 5 years after diagnosis, but those individuals who started smoking before this age entered risk as regular smokers. Multivariable logistic regression was used to obtain odds ratios (ORs) of current regular smoking (and 99% CIs) in the BCCSS vs the general population of Britain ( 31 ), with adjustment for key demographic and social variables identifi ed in the internal analysis and by the GHS ( 29 ) . We used a multivariable generalized estimating equation (GEE) logistic regression model to take into account household clustering within the GHS; a weighting factor for the GHS data was used to compensate for nonresponse in the GHS and to match the GHS sample to known population distributions. Statistical signifi cance was defi ned as P less than .01.
We also used a multivariable GEE linear regression model together with the weighting factor from the GHS to compare the mean number of cigarettes smoked per day among current regular smokers between the BCCSS and the general population. Because of the much smaller sample sizes available (eg, there were only 47 current regular smokers among survivors of heritable retinoblastoma), statistical signifi cance for this analysis only was defi ned as P less than .05 and 95% CIs were estimated.
Results
Characteristics of Participants
Of the 14 836 survivors who were eligible to receive a questionnaire, 10 483 (70.7%) returned a completed questionnaire; of these, 10 326 (98.5%) could be classified according to their smoking status. A total of 20.0% of the survivors were classified as current regular smokers, and 29.8% were classified as ever regular smokers ( Table 1 ). Approximately 21.1% of the current regular smokers smoked an average of 20 or more cigarettes per day. Among the ever regular smokers, 88.0% had initiated smoking at age 20 years or younger; 52.2% had initiated smoking at age 16 years or younger and 35.8% at 17 -20 years of age. Among the ever regular smokers, 51 started smoking before they were diagnosed with their childhood cancer and were excluded from further analyses, and an additional 508 started smoking before 5 years after their diagnosis. Table 2 presents the frequencies of current regular smoking by potential demographic, cancer, treatment, social, and economic explanatory factors. From the multivariable modeling, age at questionnaire completion, childhood cancer type, treatment with radiotherapy, socioeconomic classification, marital status, level of educational attainment, and whether on long-term regular hospital follow-up were associated with being a current regular smoker ( P < .01) ( Table 2 ). In the multivariable model, an analysis by age at questionnaire completion showed that current regular smoking was most prevalent among those aged 20 -34 years at questionnaire completion compared with those aged 16 -19 years (OR for 20-to 24-year olds = 1.29, 99% CI = 0.82 to 2.02; OR for 25-to 34-year olds = 1.30, 99% CI = 0.83 to 2.03). An analysis by childhood cancer type showed that compared with those diagnosed with a CNS neoplasm, among whom the prevalence of current smoking was the lowest, those diagnosed with Wilms tumor (OR = 2.75, 99% CI = 1.79 to 4.23), Hodgkin lymphoma (OR = 2.63, 99% CI = 1.70 to 4.05), soft tissue sarcoma (OR = 2.34, 99% CI = 1.60 to 3.43), or leukemia (OR = 2.20, 99% CI = 1.42 to 3.39) were those with the highest prevalence of current regular smokers. Survivors of heritable retinoblastoma (OR = 1.38, 99% CI = 0.66 to 2.89) were the only group of survivors who were not statistically significantly different from survivors of a CNS neoplasm in the likelihood of being a current regular smoker. Survivors who received radiotherapy treatment for their childhood cancer (OR = 0.69, 99% CI = 0.56 to 0.85) were less likely to be a current regular smoker compared with those not so treated. Compared with those in the highest socioeconomic group (ie, those in managerial or professional occupations), those in the lowest socioeconomic group (ie, those in routine or manual occupations) were more likely to be a current regular smoker (OR = 1.59, 99% CI = 1.23 to 2.05). Compared with those who were single, those who were separated, widowed, or divorced were more likely to be a current regular smoker (OR = 1.46, 99% CI = 1.07 to 2.00). Compared with those who had failed to pass or take any standard public educational examination, those with increasingly higher levels of educational attainment were increasingly less likely to be a current regular smoker ( P trend < .001). Compared with those not on long-term regular hospital follow-up, those on long-term follow-up were less likely to be a current regular smoker (OR = 0.68, 99% CI = 0.56 to 0.84). In the test for heterogeneity, age at diagnosis was not statistically significantly associated with being a current regular smoker ( P heterogeneity = .016), but there was a statistically significant trend for increasing likelihood of being a current smoker with increasing age at diagnosis ( P trend = .004).
Risk Factors Associated With Being a Current Regular Smoker
Risk Factors Associated With Age at Initiation of Regular Smoking
The actuarial estimated risks of initiating regular smoking by ages 20 and 40 years were 26.2% (99% CI = 24.9% to 27.5%) and 34.0% (99% CI = 32.6% to 35.5%), respectively. When the survivors who started smoking after their diagnosis but before they had survived 5 years were included, risks for smoking initiation by ages 20 and 40 years had increased to 32.0% (99% CI = 30.6% to 33.3%) and 39.2% (99% CI = 37.7% to 40.6%), respectively ( Figure 1 ). * For some survivors, the amounts were zero because they indicated that they smoked less than 1 cigarette per day (current regular smoker, n = 37; ever regular cigarette smoker, n = 79). † For the statistical analysis, the ages provided on the questionnaire (as whole years) by the survivor were taken to the midpoint of the year provided. * OR = odds ratio; CI = confidence interval; CNS = central nervous system. † The P value (two-sided) is from the likelihood ratio test for heterogeneity in the probability of being a current regular smoker across different levels of the specified explanatory factor for the univariate analysis and with adjustment for all other factors in the multivariable model. The threshold for statistical significance was .01. ‡ The P trend is from the test for trend and the P value in parentheses is from the test for departure from a linear trend. Both P values are two-sided. The threshold for statistical significance was .01. § The 51 survivors who started smoking before their diagnosis were excluded from analysis.
|| Heritable retinoblastoma includes those with a family history of retinoblastoma and/or who were diagnosed with bilateral retinoblastoma; all other cases of retinoblastoma were classified as nonheritable retinoblastoma. ¶ Other neoplasms include Burkitt lymphomas; intracranial and intraspinal germ cell tumors; gonadal germ cell tumors; other and unspecified nongonadal germ cell tumors; thyroid carcinomas; and malignant melanoma, skin carcinoma, and other less frequently occurring carcinomas.
# These values do not add up to the total because of exclusion of those with no record of treatment (chemotherapy, n = 3173; radiotherapy, n = 2930; surgery, n = 2729) and unusable or missing data (socioeconomic classification [SEC]: missing data or occupations given were inadequately described or could not be used to classify SEC, n = 779; legal marital status: missing data, n = 243; region: survivors who lived in Northern Ireland or the Channel Islands [n = 12] were excluded from the analysis; educational attainment: missing data, n = 374; whether on long-term regular hospital follow-up: missing data, n = 315). ** For socioeconomic classification, the survivor's present or most recent occupation was used to classify survivors with "managerial and professional occupations," "intermediate occupations," or "routine and manual occupations" defined by the 2002 General Household Survey (29); two further categories were added: "student" and "never worked or unemployed" due to the British Childhood Cancer Survivor Study population characteristics. † † For socioeconomic classification, the tests for trend and for departure from a linear trend were completed using the first three levels of the factor: managerial and professional, intermediate, and routine and manual occupations. ‡ ‡ Region was based on government office regions in Great Britain (29) and was established using the survivor's address at questionnaire completion, or if not available, the location of their registered general practitioner (GP). § § The different levels for the educational attainment relate to formal educational qualifications in Great Britain, which include level 1, which corresponds to a low level of qualification obtained in Great Britain (eg, General Certificate of Secondary Education); level 2, which corresponds to an intermediate level of educational attainment (eg, Advanced Level qualification); and level 3, the highest level of qualification, a first degree or higher.
|| || Information obtained from the consent form returned from the GP, which asked whether the survivor was on long-term regular hospital follow-up in relation to his/her childhood neoplastic disease. In the multivariable model, age at initiation of regular smoking was associated with sex, childhood cancer type, age at diagnosis, treatment with chemotherapy, treatment with radiotherapy, and third-party completion of the questionnaire ( P < .01) ( Table 3 ) . Women had a lower rate of initiating regular smoking than men (hazard ratio [HR] = 0.84, 99% CI = 0.74 to 0.95). Survivors of heritable retinoblastoma (HR = 1.15, 99% CI = 0.74 to 1.79) were the only group of survivors who were not statistically signifi cantly different from survivors of a CNS neoplasm in their rate of initiation of regular smoking; survivors of all other childhood cancer types had higher rates of smoking initiation, particularly survivors of Hodgkin lymphoma (HR = 2.30, 99% CI = 1.69 to 3.11) and Wilms tumor (HR = 2.38, 99% CI = 1.82 to 3.13), who had smoking initiation rates that were more than double that of survivors of CNS neoplasms. Survivors who were diagnosed with cancer at ages 10 -14 years had the highest rate of initiating smoking at 1.27 times (99% CI = 1.05 to 1.54) that of those who were diagnosed with cancer at ages 0 -4 years. The rates of smoking initiation among survivors whose childhood cancer was treated with chemotherapy (HR = 0.73, 99% CI = 0.61 to 0.87) or radiotherapy (HR = 0.81, 99% CI = 0.70 to 0.94) were lower than those among survivors who did not have such treatments. Survivors who completed the questionnaire with the help of a third party had a lower rate of smoking initiation than those who completed the questionnaire themselves (HR = 0.72, 99% CI = 0.57 to 0.91).
Inclusion of the time-dependent variables (as measured at the time of questionnaire completion) in the multivariable Cox regression model had minimal effect on the hazard ratios or the statistical signifi cance of the tests for heterogeneity for the core demographic, cancer, and treatment factors, with the exception of thirdparty questionnaire completion, which was no longer a statistically signifi cant risk factor for age at initiation of regular smoking (HR = 0.81, 99% CI = 0.62 to 1.06, P = .038).
Inclusion of the survivors who started smoking after diagnosis but within 5 years of their diagnosis in the survival analysis did not appreciably change the hazard ratios or statistical signifi cance of the tests for heterogeneity from the multivariable model for any factor examined except for age at diagnosis; survivors who were diagnosed at ages 10 -14 years had an increased rate of initiating smoking compared with those who were diagnosed at ages 0 -4 years (HR = 2.51, 99% CI = 2.13 to 2.97, P heterogeneity < .001). This increase in hazard ratio after including these additional survivors was not unexpected, given that 93% of these survivors were diagnosed at age 10 -14 years (whereas only 7% were diagnosed at age 5 -9 years and less than 1% at age 0 -4 years). For the 5-to 9-yearold diagnosis group, the hazard ratio (HR = 1.10, 99% CI = 0.94 to 1.28) did not change appreciably after including the survivors who started smoking after diagnosis but before they had reached 5 years after their diagnosis.
Smoking Rates Among Childhood Cancer Survivors Compared With the General Population of Britain
Survivors of childhood cancer in the BCCSS had approximately half the odds of being a current regular smoker than the general population of Britain (OR = 0.51, 99% CI = 0.46 to 0.57; Table 4 ). (Given that the rate of current regular smoking was over 20%, however, it should be noted that the odds ratios exaggerate the actual relative risks.) The only survivors who did not have statistically significantly lower odds of being a current regular smoker than the general population were those who had been diagnosed with nonheritable retinoblastoma (OR = 0.79, 99% CI = 0.57 to ( Table 4 ) .
The current regular smokers within the BCCSS smoked statistically signifi cantly fewer cigarettes per day than current regular smokers in the general population (mean number of cigarettes smoked per day for BCCSS vs the general population: 11.78 vs 14.29; difference between the BCCSS and the general population in number of cigarettes smoked per day from the multivariable linear regression model = 1.5, 95% CI = 1.03 to 1.99) ( Table 5 ) . The difference in mean number of cigarettes smoked per day compared with the general population was statistically signifi cant at the 5% level for survivors of Wilms tumor, a CNS neoplasm, nonheritable retinoblastoma, leukemia, heritable retinoblastoma, and Hodgkin lymphoma.
Discussion
Our data indicate that the prevalence of smoking among adult survivors of childhood cancer in the BCCSS was substantially less than that in the general population (OR = 0.51, 99% CI = 0.46 to 0.57) and that overall, the childhood cancer survivors who currently smoked, smoked fewer cigarettes per day on average than the general population. Among survivors in the BCCSS, 20% were classified as being a current regular smoker, approximately 30% were classified as being an ever regular smoker, and an estimated 34% -39% of the survivors had started smoking regularly by age 40 years. Within the comparable general population (ie, those younger than 70 years), 28.1% were classified as a current regular smoker and 48.8% as an ever regular smoker ( 31 ) , although the general population includes a higher proportion of older individuals than the BCCSS. The proportions within the BCCSS are similar to those reported in the North American Childhood Cancer Survivor Study (CCSS): among 9709 survivors who were 20 years or younger at cancer diagnosis between 1970 and 1986 and currently 18 -47 years old, 17% were current smokers, 28% were ever smokers, and the actuarial estimated incidence of initiating smoking by age 40 years was 32% ( 19 ) . Other studies ( 20 , 22 -26 , 28 , 32 , 33 ) have reported levels of current smoking among survivors that varied from 14% to 33%. However, comparisons of smoking rates of survivors in different studies are often very difficult because of uncontrolled confounding by many factors, including the types of childhood cancer included, the age of the survivors, and the time from diagnosis; in addition, the methods used to classify smoking status often vary among studies.
The internal analysis revealed that survivors of Hodgkin lymphoma, soft tissue sarcoma, or Wilms tumor were more likely to be current smokers, had greater rates of initiating regular smoking, and had some of the highest odds of current smoking prevalence compared with that in the general population than survivors of other types of childhood cancer. These fi ndings are troubling because survivors of Hodgkin lymphoma and soft tissue sarcoma are at a particularly increased risk of a second malignant neoplasm ( 8 , 34 , 35 ) . Other studies ( 36 , 37 ) have reported an increased risk of a second malignant neoplasm in Wilms tumor survivors, particularly those who have undergone abdominal or lung irradiation. It is unclear why more survivors of Hodgkin lymphoma, Wilms tumor, and soft tissue sarcoma would have started smoking than survivors of other cancers. Factors other than sociodemographic factors that have been reported to be associated with engagement in unhealthy lifestyle behaviors among adolescents include personality traits, parental support, family structure, and parental and peer modeling of behaviors ( 38 ) , none of which were examined here. In addition, treatment-related factors, knowledge of risks, perceived vulnerability to the health risks of smoking, and an ability to make decisions have also been reported to be associated with engagement in unhealthy lifestyle behaviors among survivors of * HR = hazard ratio; CI = confidence interval; CNS = central nervous system . † The P value (two-sided) is from the likelihood ratio test of heterogeneity for age at smoking initiation across different levels of the specified factor for the univariate analysis and with adjustment for sex, childhood cancer type, age at diagnosis, chemotherapy, radiotherapy, surgery, and third party -completed questionnaire in the multivariable model. The threshold for statistical significance was .01. ‡ The main P value is from the test for trend, and the P value in parentheses is from the test for departure from a linear trend. Both P values are two-sided and the threshold for statistical significance was .01.
childhood cancer ( 38 ) . Further study is needed to determine which of these factors are associated with current smoking in the survivors from the BCCSS using, for instance, a structured interview with particular reference to the previously highlighted psychosocial factors. Survivors of childhood cancer have been reported to be at an increased risk of a second malignant neoplasm that is approximately six times higher than that expected, and this increased risk varies with treatment type and intensity ( 7 , 8 ) . Being a smoker and smoking for a considerable period are likely to further increase the risk of a second malignant neoplasm among survivors who have an established excess risk attributable to treatment. For example, smoking has been shown to increase the risk of lung cancer in survivors of Hodgkin lymphoma in addition to the increased risks from radiotherapy and chemotherapy ( 39 , 40 ) . It is therefore imperative that survivors who have been treated with chemotherapy and/or radiotherapy do not smoke. Survivors in the BCCSS who were treated with radiotherapy for their childhood cancer were less likely to be a current smoker and had a reduced rate of initiating regular smoking than those who did not receive radiotherapy. Chemotherapy treatment, in particular with anthracyclines and epipodophyllotoxins, is also associated with an increased risk of a second malignant neoplasm ( 8 ) . We found that BCCSS Table 4 * The percentage of current regular smokers in the general population aged between 16-69 y was 28.1% (31) . The general estimating equation multivariable logistic regression controlled for age group at questionnaire completion [only those younger than 70 years were included in the age group " ≥ 50 y" because educational attainment was only requested from individuals aged up to and including 69 years in the general household survey (29)], sex, legal marital status; socioeconomic classification, educational attainment, and region and took into account the General Household Survey weighting factor. OR = odds ratio; CI = confidence interval. † Population data from the General Household Survey was used for the reference group ( 31 ). survivors who were treated with chemotherapy for their childhood cancer had a lower rate of initiating smoking and were less likely to be current smokers (borderline statistical signifi cance) than those who did not receive chemotherapy. It is encouraging that relatively fewer survivors of heritable retinoblastoma were current smokers than were survivors of all other specifi c childhood cancer types (including nonheritable retinoblastoma) except CNS neoplasms. The odds of heritable retinoblastoma survivors being a current regular smoker were half those of the corresponding general population. Survivors of heritable retinoblastoma also had one of the lowest rates of initiating regular smoking compared with survivors of other childhood cancers. It is important that hereditary retinoblastoma survivors do not smoke because they are known to have a high risk of a second malignant neoplasm ( 15 , 41 ) , which is largely attributable to germline mutations they carry in the RB1 gene ( 42 ) . Foster et al. ( 20 ) also reported levels of current smoking similar to those seen here: among 1-year survivors of heritable and nonheritable retinoblastoma with a mean age of 35 years, the majority of whom were diagnosed between 1960 and 1984, the prevalence of current smoking was 17% and 24%, respectively, both of which were statistically signifi cantly lower than the population rates. Foster et al. ( 20 ) suggested that higher educational attainment in the retinoblastoma survivors might explain their lower smoking prevalence compared with that seen in the general population. Here, we found that among all childhood cancer survivors, those with higher educational attainment were less likely to be a smoker than those who failed to pass or to take any standard public educational examination. However, we cannot infer that a higher educational attainment in the heritable retinoblastoma survivors contributed to the lower smoking prevalence because in both the internal and external analyses we included educational attainment in the multivariable models and observed that the heritable retinoblastoma survivors still had one of the lowest prevalences of smoking. Therefore, other unidentifi ed factors could also be contributing to the lower prevalence of smoking in the hereditary retinoblastoma survivors. For example, it is possible that because of their genetic predisposition for a second malignant neoplasm, the heritable retinoblastoma survivors may have received more intensive and focused counseling on lifestyle behaviors, which may have contributed to their lower prevalence of smoking.
Only the survivors of a CNS neoplasm had a lower rate of initiating smoking than survivors of a heritable retinoblastoma. Emmons et al. ( 19 ) also reported a reduced rate of smoking initiation in CNS neoplasm survivors in the CCSS, which they suggested could be a consequence of treatment-related neuropsychological defi cits in the CNS neoplasm survivors . This suggestion seems plausible because CNS neoplasm survivors are particularly susceptible to neuropsychological late effects, which range from cognitive impairments to severe learning disabilities that lead to a high level of dependence on others ( 43 , 44 ) ; such defi cits could exclude these survivors from situations where they might start smoking or limit their opportunity to smoke. Neuropsychological function is also associated with age at diagnosis, and survivors who are younger at diagnosis fare worse than those who are older at diagnosis ( 43 ) . Neuropsychological defi cits present in those diagnosed at a young age may have contributed somewhat to the lower prevalence of smoking among survivors in the BCCSS who were diagnosed before 10 years of age. In the CCSS, a cancer diagnosis at a young age (younger than 10 years) was also associated with a lower risk of smoking initiation than in those diagnosed at age 10 years or older ( 19 ) .
Several reports ( 25 , 38 , 45 ) indicate that survivors of childhood cancer do not differ from their peers who were not diagnosed with a childhood cancer with respect to associations between sociodemographic factors and smoking initiation. The survivors in the BCCSS were also not different from the British general population with respect to the sociodemographic factors associated with being a current smoker ( 29 ) . Higher rates of smoking have been observed in the general population and also in the BCCSS (albeit at a somewhat lower level of smoking in the latter) among those aged 20 -34 years, men, individuals in routine and manual occupations, and those not currently married compared with the complementary groups (as detailed in Table 2 ) ( 29 ) . Survivors who failed to pass or take any standard public educational examination were more likely to be a current regular smoker than those with some level of educational attainment. Other studies ( 20 , 24 ) have shown that survivors who were less educated were more likely to be a current smoker, and education has been shown to be associated with smoking initiation in the CCSS ( 19 ) . Limited educational attainment has been associated with fatalistic beliefs about cancer prevention, and such fatalistic beliefs have been shown to be associated with smoking ( 46 ) . For survivors with fatalistic beliefs, smoking interventions should emphasize the fact that individuals can have an appreciable impact on reducing their risk of a second malignant neoplasm by their lifestyle choices.
This study has several strengths. It is the largest ever such population-based cohort study, and it included all types of childhood cancer and had extended follow-up times for the survivors; 48% of the survivors have been followed up for at least 20 years after reaching 5 years of survival subsequent to their diagnosis ( 30 ) .
Our study has three limitations that should be considered when interpreting the results. First, we included third party -completed questionnaires. Exclusion of the third-party questionnaires did not appreciably change the conclusions from the external analysis to when all questionnaires were analyzed. For the internal analysis, we included all survivors, regardless of whether their questionnaires were completed by the survivor or by a third party, and entered third-party completion as a factor in the multivariable model. We found that survivors whose questionnaires were completed by a third party had a lower rate of initiating smoking than those who self-completed a questionnaire. This association could have several possible explanations. On the one hand, the reduced rate of smoking initiation among survivors with third partycompleted questionnaires could be linked to a physical or mental disability that prevented self-completion of the questionnaire. Survivors in the BCCSS who were diagnosed during childhood with heritable retinoblastoma or a CNS neoplasm had the highest proportion of third party -completed questionnaires (33.7% and 24.6%, respectively) ( 30 ) . Alternatively, the lower rate of smoking initiation in survivors with a third party -completed questionnaire may refl ect the fact that the person who completed the questionnaire did not have complete information about the survivor's use of cigarettes. However, we requested that all third partycompleted questionnaires be completed in the presence of the survivor whenever possible, which should have led to improved accuracy in the smoking data reported, as has been suggested by others who have used proxy reports on smoking status ( 47 , 48 ) .
A second possible limitation of this study is the accuracy of the self-reported smoking data. The smoking data for all survivors were based on responses to a questionnaire rather than on biochemical data, which could call into question their accuracy. However, a review of studies that used biochemical validation of self-reported smoking status found that although sensitivity and specifi city of self-reporting varied by study, they were high overall (mean sensitivity and specifi city = 87% and 89%, respectively) ( 49 ) . The authors of the GHS report acknowledged that cigarette consumption and prevalence may have been underestimated ( 29 ) , but the extent of any underestimation among the general population or the survivors in the BCCSS is unknown.
A third limitation is that this analysis did not include information relating to the 2780 of the 17 981 5-year survivors who died before we could ascertain their smoking status. It is possible that some of these deaths may have been related to the survivor's smoking behavior, and, consequently, that the survivors who died may have had a higher prevalence of smoking than reported here for those who were alive. However, given that 43% of the 2780 survivors died at age 16 years or younger, it is unlikely that the smoking behavior of these young individuals who died was the main cause of their death. The most common cause of death in survivors who die in the initial 10-year period following 5-year survival is a cancer recurrence ( 50 ) . Cohort members who died from a cancer recurrence are likely to have had less of an opportunity to start smoking than those who did not experience a recurrence, which would have resulted in a lower prevalence of smoking in the entire 17 981-member cohort than what we observed among the survivors who provided their smoking status on the questionnaire.
Although the childhood cancer survivors had a substantially lower smoking prevalence than the general population, the smoking prevalence in this vulnerable group should be reduced even further. Advice on the health risks of smoking should be included in any program of clinical follow-up for survivors of childhood cancer. However, Taylor et al. ( 51 ) reported that 65% of adult survivors of childhood cancer in Britain were not on long-term regular hospital follow-up for their cancer. Clinical follow-up guidelines for children and adolescents in Britain ( www.cclg.org.uk and www. sign.ac.uk ) and in North America ( www.survivorshipguidelines. org ) recommend that survivors should not start smoking and that those who do should stop. The guidelines also provide information on the health risks of smoking in relation to specifi c cancer treatments, such as alkylating agents, and radiation to the lungs, heart, abdomen, or pelvis. We found that the BCCSS survivors who were on long-term regular hospital follow-up were less likely to be current smokers than those not on follow-up. It is encouraging that those attending clinical follow-up programs appear to have a lower level of smoking than those survivors not attending such a program; however, those on such programs are likely to have different attributes than those not on such programs ( 51 ) .
In conclusion, although the extent of smoking among survivors of childhood cancer diagnosed in Britain between 1940 and 1991 was less than that seen in the comparable general population, levels of smoking prevalence among survivors should be reduced further, particularly among survivors of Wilms tumor, Hodgkin lymphoma, and soft tissue sarcoma. Results of this study and data from the CCSS ( 19 ) and the GHS for the general population of Britain ( 29 ) indicate that interventions to prevent initiation of smoking among survivors of childhood cancer need to start early in a survivor's life because the majority of individuals who start to smoke do so by the age of 20 years. A recent review revealed that few interventions have been designed primarily to prevent the initiation of smoking in survivors of childhood cancer ( 52 ) . In a randomized controlled trial, Tyc et al. ( 53 ) reported that adolescent survivors who received a risk counseling intervention had statistically significantly better health knowledge scores, higher perceived vulnerability scores, and lower smoking intention scores than those who received standard care. Because factors that predict smoking initiation in childhood cancer survivors have been shown to be similar to those in healthy adolescents ( 25 , 38 ) , Klosky et al. ( 45 ) have suggested that smoking prevention interventions that have been developed for healthy adolescents could be used for adolescent survivors of childhood cancer. For example, a well-designed family intervention or a multicomponent community program, which have been shown to assist smoking prevention in healthy adolescents ( 54 , 55 ) , could potentially be used in adolescent survivors of cancer. Preventive interventions would not be appropriate for the BCCSS cohort because a large proportion of the participants are older than 20 years of age but should be undertaken among more recently diagnosed survivors of cancer, ideally those aged 12 -20 years.
Smoking cessation interventions would be more appropriate for the BCCSS cohort than smoking prevention interventions because a high proportion of the survivors were older than the age at which most individuals initiate smoking (ie, ≤ 20 years of age). A telephone-based peer-delivered smoking cessation intervention has been used successfully with adult survivors of childhood cancer: those who received the intervention had a statistically significantly higher quit rate than those in a self-help group ( 56 ) , and those who used nicotine replacement therapy had more quit attempts than those who did not use this therapy ( 57 ) . Numerous smoking cessation methods, such as individual counseling and pharmacological treatments, have been used with success in the general population ( 58 ) , although some, such as the antidepressant bupropion, are not advisable for survivors of some types of cancer [eg, those with a history of seizures or a CNS neoplasm ( 45 ) ]. Novel cessation intervention strategies, such as the nicotine vaccine that is currently being developed, may be an alternative way to help survivors of childhood cancer to stop smoking ( 45 ) . Research is required to examine whether interventions that are used or designed to help healthy individuals to stop smoking ( 45 , 58 ) have the same effects on the smoking behavior of childhood cancer survivors. This study has highlighted the groups of childhood cancer survivors that are at higher risk of smoking and among whom successful interventions should be targeted.
